Skip to content

Ap-FGF-CPS trial

Clinical trial of fibroblast growth factor-2-apatite composite layer coating cervical pedicle screw of posterior cervical spinal fusion. - Ap-FGF-CPS trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031180078
Enrollment
10
Registered
2019-01-11
Start date
2018-08-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical disorder (spondyloarthrosis, spinal osteoarthritis) Cervical spine, posterior fusion surgery

Interventions

Sponsors

Yamazaki Masashi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients undergoing posterior cervical spinal fusion(from C2 or C3 to C7 or T1 fusion) 2. 20 years old or more and less than 90 years old

Exclusion criteria

Exclusion criteria: 1. The patient who has past history of cervical surgery, pyogenic spondylitis, and vertebral tumor. 2. The patient who receives cervical anterior fusion surgery 3. The patient who received other study drugs within current three months 4. The diabetic that it is poor in control 5. The patient who cannot be inserted caudal end screw of fixed range 6. The patient who has a serious heart disorder 7. The patient who has a serious hepatic dysfunction(AST(GOT)or ALT(GPT) is more than 100u) 8. The patient who has a serious renal dysfunction(BUN is more than 25mg/dL or serum creatinine is more than 2.0 mg/dL) 9. The patient who has a doubt or diagnostic neoplastic lesion within 5 years before agreement. 10. The woman that during the pregnancy or the pregnancy is doubted 11. The woman that during breastfeed. 12. The patient who has an allergy to metal. 13. The patient who has an allergy to Fiblastspray. 14. The patient who has not ability for agreement with own will. 15. The patient who has not ability for agreement by the reading and writing 16. The patient who has been judged to be inappropriate as a subject by the doctor incharge

Design outcomes

Primary

MeasureTime frame
Incidence of all adverse events that occurred during the clinical trials such as infection, death, fracture, neoplasma, or neuropathy due to the Ap-FGF pedicle screws.

Secondary

MeasureTime frame
Incidence of loosening and breakage of each pedicle screw. Time for bone union JOA score, JOACMEQ

Contacts

Public ContactYuki Hara

University of Tsukuba Hospital

yukihara@md.tskuba.ac.jp+81-29-853-3219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026